LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells
出版年份 2019 全文链接
标题
LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells
作者
关键词
-
出版物
Oncogenesis
Volume 8, Issue 11, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-10-16
DOI
10.1038/s41389-019-0170-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
- (2019) Dong-ming Wu et al. Cell Death & Disease
- Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis
- (2019) Na Yao et al. ONCOGENE
- Long noncoding RNAs in cancer cells
- (2018) Duc-Hiep Bach et al. CANCER LETTERS
- PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα
- (2018) Higinio Dopeso et al. CANCER RESEARCH
- Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment
- (2018) Zhenqiang Sun et al. Molecular Cancer
- HOXB7 overexpression in lung cancer is a hallmark of acquired stem-like phenotype
- (2018) Simona Monterisi et al. ONCOGENE
- Long Noncoding RNA in Cancer: Wiring Signaling Circuitry
- (2018) Chunru Lin et al. TRENDS IN CELL BIOLOGY
- HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway
- (2017) Xianxiang Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
- (2017) Yuanyuan Lu et al. NATURE MEDICINE
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- LncRNA-mediated regulation of cell signaling in cancer
- (2017) W-X Peng et al. ONCOGENE
- Temporal and spatial requirements for Hoxa3 in mouse embryonic development
- (2016) Jena L. Chojnowski et al. DEVELOPMENTAL BIOLOGY
- Long non-coding RNAs in cancer drug resistance development
- (2016) Maryam Majidinia et al. DNA REPAIR
- Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis
- (2016) Hao Sun et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Enforced Expression of Hoxa3 Inhibits Classical and Promotes Alternative Activation of Macrophages In Vitro and In Vivo
- (2016) Hadeel Al Sadoun et al. JOURNAL OF IMMUNOLOGY
- Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis
- (2016) Chunyang Jiang et al. Molecular Cancer
- Epithelial–mesenchymal transition: a new target in anticancer drug discovery
- (2016) Fabrizio Marcucci et al. NATURE REVIEWS DRUG DISCOVERY
- NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma
- (2016) Shuang Lin et al. ONCOLOGY REPORTS
- Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
- (2016) Julia Beermann et al. PHYSIOLOGICAL REVIEWS
- Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells
- (2016) Xin-Xing Zhu et al. Oncotarget
- Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma
- (2016) Iben Daugaard et al. Scientific Reports
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- Multiple roles for HOXA3 in regulating thymus and parathyroid differentiation and morphogenesis in mouse
- (2014) J. L. Chojnowski et al. DEVELOPMENT
- Development of oculomotor circuitry independent of hox3 genes
- (2014) Leung-Hang Ma et al. Nature Communications
- DNA Based Therapy with Diphtheria Toxin-A BC-819: A Phase 2b Marker Lesion Trial in Patients with Intermediate Risk Nonmuscle Invasive Bladder Cancer
- (2013) Ofer N. Gofrit et al. JOURNAL OF UROLOGY
- Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer
- (2012) N Hanna et al. CANCER GENE THERAPY
- Aerosolized BC-819 Inhibits Primary but Not Secondary Lung Cancer Growth
- (2011) Günther Hasenpusch et al. PLoS One
- Hoxa3 promotes the differentiation of hematopoietic progenitor cells into proangiogenic Gr-1+CD11b+ myeloid cells
- (2010) E. Mahdipour et al. BLOOD
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
- Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
- (2009) Aya Mizrahi et al. Journal of Translational Medicine
- HOXA3 Modulates Injury-Induced Mobilization and Recruitment of Bone Marrow-Derived Cells
- (2009) Kimberly A. Mace et al. STEM CELLS
- Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin
- (2008) Abraham Ami Sidi et al. JOURNAL OF UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started